Table 1 Overview of cultured multidrug-resistant bacteria with genotype and phenotype

P22

Post-FMT

E. coli

Aminoglycoside, fluoroquinolone, ampC

APH(3’)-Ia, APH(6)-Id, APH(3″)-Ib, ANT(2″)-Ia, acrD, ampC, QnrB5, emrR

Yes

P30

Post-FMT

E. coli

Aminoglycoside, fluoroquinolone

acrD, emrR, emrD

Yes

P31

Pre-FMT

E. coli

Aminoglycoside, fluoroquinolone, ceftazidime

acdD, emrR, emrB, ampC

Yes

P33

Pre-FMT

K. pneumoniae^a

Aminoglycoside, fluoroquinolone, ESBL

aadA2, aadA16, AAC(3-IId, TEM-1, SHV-119, CTX-M-14

Yes

P33

Post-FMT

K. pneumoniae^a

Aminoglycoside, fluoroquinolone, ESBL

aadA2, aadA16, AAC(3-IId, TEM-1, SHV-119, CTX-M-14

Yes

P38

Pre-FMT

E. coli^a

Fluoroquinolone, ESBL

CTX-M-27, ermR, emrB

Yes

P38

Post-FMT

E. coli^a

Fluoroquinolone, ESBL

CTX-M-27, ermR, emrB

Yes

P39

Pre-FMT

E. coli

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-15, OXA-1, acrD, AAC(3)-IIe, emrA, emrB, emrR

Yes

P44

Pre-FMT

C. freundii^a

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-15, OXA-1, AAC(3)-IIe, AAC(6’)-Ib-cr, APH(6)-Id, APH(3″)-Ib, QnrB6

Yes

P44

Post-FMT

C. freundii^a + E. coli

Aminoglycoside, fluoroquinolone, ESBL + ESBL

CTX-M-15, OXA-1, AAC(3)-IIe, AAC(6’)-Ib-cr, APH(6)-Id, APH(3″)-Ib, QnrB17

Yes

P44

LTFU (3 yr)

E. coli

ESBL

NA

NA

P51

Pre-FMT

C. freundii

ESBL

CTX-M-9

Yes

P58

Pre-FMT

E. coli

Aminoglycoside, fluoroquinolone

acrD, emrR

Yes

P59

Pre-FMT

E. coli^a

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-14, acrD, AAC(3)-IIe, APH(3″)-Ib, APH(6)-Id, emrR

Yes

P59

Post-FMT

E. coli^a

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-14, acrD, AAC(3)-IIe, APH(3″)-Ib, APH(6)-Id, emrR

Yes

P59

LTFU (1 yr)

E. coli^a

Aminoglycoside, fluoroquinolone, ESBL

NA

NA

P64

Pre-FMT

E. coli^a

Aminoglycoside, fluoroquinolone

AAC(6’)-Ib-cr, emrA, emrB, emrR

NA

P64

Post-FMT

E. coli^a

Aminoglycoside, fluoroquinolone

acrD, APH(3")-Ib, APH(6)-Id, ampC, ampH, emrA, emrB, emrR

NA

P65

Pre-FMT

E. hormaechei_A (cloacae)

Aminoglycoside, fluoroquinolone, ESBL

ACT-27, CTX-M-15, OXA-1, TEM-1, AAC(3)-IIe, APH(6)-Id, APH(3")-Ib, AAC(6')-Ib-cr, QnrB6

NA

P66

Pre-FMT

M. morganii

ESBL

DHA-18

NA

P67

Pre-FMT

P. mirabilis

ESBL

CTX-M-1

NA

P68

Pre-FMT

P. mirabilis_B (vulgaris/mirabilis)

ESBL

(none)^b

NA

P69

Pre-FMT

C. freundii^a

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-15, TEM-1, OXA-1, AAC(3)-IIe, APH(3″)-Ib, APH(6’)-Id, QnrB6

NA

P69

Post-FMT

C. freundii^a

Aminoglycoside, fluoroquinolone, ESBL

CTX-M-15, TEM-1, OXA-1, AAC(3)-IIe, APH(3″)-Ib, APH(6’)-Id, QnrB17

NA

P70

Pre-FMT

E. coli^a

ESBL

ampC, ampH, SHV-134

NA

P70

Post-FMT

E. coli^a

ESBL

ampC, ampH, SHV-134

NA

P71

Pre-FMT

K. pneumoniae

ESBL

NA

NA

P72

Pre-FMT

P. hauseri

ESBL

NA

NA

P73

Pre-FMT

C. freundii

ESBL

NA

NA

P74

Pre-FMT

E. cloacae

ESBL

NA

NA

P75

Pre-FMT

E. cloacae^a

ESBL

NA

NA

P75

Post-FMT

E. cloacae^a

ESBL

NA

NA